Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty

August 2009

You'll soon see Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty.

Think of it as a more powerful cousin to clopidogrel (Plavix).

Effient is more effective than clopidogrel for preventing MIs after angioplasty...but it also causes more bleeding.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote